Fatal pulmonary embolism in patients on antipsychotics : case series, systematic review and meta-analysis
Copyright © 2022 Elsevier B.V. All rights reserved..
Since the 1950 s, several studies have reported that patients using first generation and/or second-generation antipsychotics had increased risk of venous thromboembolism events. These events include deep vein thrombosis and/or pulmonary embolism (PE). However, data about fatal PE in patients on antipsychotics (APs) remain scarce. Thus, the current study aimed to investigate sociodemographic, clinical and pharmacological characteristics related to psychiatric patients on APs and who died from a fatal PE. We reported a case-series, then conducted a literature review of relevant studies and performed a meta-analysis of studies with usable data. The main outcome of the study suggested a significantly high risk of fatal PE in patients using APs compared to nonusers (Odds Ratio=6.68, with 95% confidence interval 1.43-31.11). Clozapine was the most incriminated drug. Low potency first generation APs were the second most exhibited medication. Studies about the topic remain scarce with a high heterogeneity and a high probability of bias. Further studies are needed to ascertain this risk and to establish target preventive measures in this particularly vulnerable population.
Errataetall: |
ErratumIn: Asian J Psychiatr. 2023 May;83:103575. - PMID 37012198 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:73 |
---|---|
Enthalten in: |
Asian journal of psychiatry - 73(2022) vom: 18. Juli, Seite 103105 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Manoubi, Syrine Azza [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antipsychotic Agent |
---|
Anmerkungen: |
Date Completed 09.06.2022 Date Revised 03.04.2023 published: Print-Electronic ErratumIn: Asian J Psychiatr. 2023 May;83:103575. - PMID 37012198 Citation Status MEDLINE |
---|
doi: |
10.1016/j.ajp.2022.103105 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM339821388 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM339821388 | ||
003 | DE-627 | ||
005 | 20231226003743.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ajp.2022.103105 |2 doi | |
028 | 5 | 2 | |a pubmed24n1132.xml |
035 | |a (DE-627)NLM339821388 | ||
035 | |a (NLM)35452966 | ||
035 | |a (PII)S1876-2018(22)00103-4 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Manoubi, Syrine Azza |e verfasserin |4 aut | |
245 | 1 | 0 | |a Fatal pulmonary embolism in patients on antipsychotics |b case series, systematic review and meta-analysis |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 09.06.2022 | ||
500 | |a Date Revised 03.04.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a ErratumIn: Asian J Psychiatr. 2023 May;83:103575. - PMID 37012198 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2022 Elsevier B.V. All rights reserved. | ||
520 | |a Since the 1950 s, several studies have reported that patients using first generation and/or second-generation antipsychotics had increased risk of venous thromboembolism events. These events include deep vein thrombosis and/or pulmonary embolism (PE). However, data about fatal PE in patients on antipsychotics (APs) remain scarce. Thus, the current study aimed to investigate sociodemographic, clinical and pharmacological characteristics related to psychiatric patients on APs and who died from a fatal PE. We reported a case-series, then conducted a literature review of relevant studies and performed a meta-analysis of studies with usable data. The main outcome of the study suggested a significantly high risk of fatal PE in patients using APs compared to nonusers (Odds Ratio=6.68, with 95% confidence interval 1.43-31.11). Clozapine was the most incriminated drug. Low potency first generation APs were the second most exhibited medication. Studies about the topic remain scarce with a high heterogeneity and a high probability of bias. Further studies are needed to ascertain this risk and to establish target preventive measures in this particularly vulnerable population | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Meta-Analysis | |
650 | 4 | |a Review | |
650 | 4 | |a Systematic Review | |
650 | 4 | |a Antipsychotic Agent | |
650 | 4 | |a Cause of Death | |
650 | 4 | |a Psychiatry | |
650 | 4 | |a Pulmonary Embolism | |
650 | 4 | |a Thromboembolism | |
650 | 7 | |a Antipsychotic Agents |2 NLM | |
650 | 7 | |a Clozapine |2 NLM | |
650 | 7 | |a J60AR2IKIC |2 NLM | |
700 | 1 | |a Boussaid, Marwa |e verfasserin |4 aut | |
700 | 1 | |a Brahim, Oumeima |e verfasserin |4 aut | |
700 | 1 | |a Ouanes, Sami |e verfasserin |4 aut | |
700 | 1 | |a Mahjoub, Yosra |e verfasserin |4 aut | |
700 | 1 | |a Zarrouk, Lazhar |e verfasserin |4 aut | |
700 | 1 | |a Mesrati, Mohamed Amin |e verfasserin |4 aut | |
700 | 1 | |a Aissaoui, Abir |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Asian journal of psychiatry |d 2008 |g 73(2022) vom: 18. Juli, Seite 103105 |w (DE-627)NLM193264730 |x 1876-2026 |7 nnns |
773 | 1 | 8 | |g volume:73 |g year:2022 |g day:18 |g month:07 |g pages:103105 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ajp.2022.103105 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 73 |j 2022 |b 18 |c 07 |h 103105 |